NewAmsterdam Pharma N.V. (NAMS)

AI Score

Unlock

17.45

-0.02 (-0.11%)

At close: Apr 25, 2025, 3:59 PM

17.52

0.40%

After-hours: Apr 25, 2025, 04:05 PM EDT

NewAmsterdam Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net Income	-232.42M	-182.78M	-212.22M	-212.18M	-163.57M	-161.48M	-120.27M	-85.08M	-45.19M	-3.93M	2.44M	2.47M	3.61M	1.36M	-1.57M	-1.91M	-5.75M	-4.31M	-2.87M	-1.44M
Depreciation & Amortization	110.66K	64.83K	42.99K	50.91K	45.23K	25.32K	19.17K	-6.46K	-14.74K	3.5K	7K	10.5K	14K	10.75K	7.5K	4.25K	1K	750.00	500.00	250.00
Stock-Based Compensation	32.5M	28.15M	25.71M	23.08M	22.71M	19.55M	14M	8.91M	1.9M	262.25K	524.5K	786.75K	1.05M	786.75K	524.5K	262.25K	n/a	n/a	n/a	n/a
Other Working Capital	-10.09M	-2.87M	1.63M	2.15M	472.82K	-4.82M	-5.34M	-2.01M	930.04K	3.82M	1.91M	120.3K	194.23K	158.29K	-27.66K	29.59K	n/a	n/a	n/a	n/a
Other Non-Cash Items	49.31M	-1.35M	5.13M	-27.46K	-26.55K	6.57M	6.53M	10.91M	9.35M	-143.9K	-4.49M	-2.88M	-3.91M	-3.5M	-1.61M	-2.37M	306K	229.5K	153K	76.5K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-30.97M	-20.56M	-17.97M	-1.81M	7.09M	63.25M	62.72M	61.89M	62.38M	3.83M	1.92M	124.56K	198.49K	26.29K	-291.66K	-366.4K	-528K	-396K	-264K	-132K
Operating Cash Flow	-151.09M	-146.1M	-168.92M	-152.04M	-130.53M	-68.86M	-33.78M	-521.94K	28.42M	-245.18K	-133.31K	-283.26K	-99.75K	-2.11M	-3.47M	-4.65M	-5.97M	-4.48M	-2.98M	-1.49M
Capital Expenditures	-630.99K	-636.86K	-571.2K	-374.03K	-22.22K	-122.78K	-113.44K	-115.87K	-109.43K	-5K	-10K	-15K	-20K	-18.25K	-16.5K	-14.75K	-13K	-9.75K	-6.5K	-3.25K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-62.18M	-2.59M	-5.18M	-5.18M	-5.18M	-2.59M	n/a	n/a	n/a	5K	722K	1.44M	2.16M	2.15M	1.44M	726.75K	13K	9.75K	6.5K	3.25K
Investing Cash Flow	-62.81M	-3.23M	-5.75M	-398.7K	-46.89K	2.44M	5.04M	-115.87K	-109.43K	-5K	707K	1.42M	2.13M	2.13M	1.42M	702.25K	-13K	-9.75K	-6.5K	-3.25K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	14M	13.13M	13.27M	14.94M	9.44M	162.12M	161.93M	155.59M	153.35M	5.44M	5.44M	22.68M	39.97M	37.33M	40.18M	25.77M	11.37M	8.53M	5.68M	2.84M
Financial Cash Flow	645.42M	188.82M	188.97M	190.43M	8.22M	161.59M	161.39M	155.59M	153.35M	17.21M	34.45M	51.7M	68.99M	54.58M	40.18M	25.77M	11.37M	8.53M	5.68M	2.84M
Net Cash Flow	424.95M	45.84M	21.17M	45.66M	-109.55M	-79.45M	-47.01M	-24.62M	-696.05K	-165.69K	-78.49K	-277.06K	-36.44K	773.45K	2.23M	3.89M	5.36M	4.02M	2.68M	1.34M
Free Cash Flow	-151.72M	-146.73M	-169.49M	-152.41M	-130.55M	-68.98M	-33.89M	-637.81K	28.31M	-250.18K	-143.31K	-298.26K	-119.75K	-2.13M	-3.49M	-4.66M	-5.98M	-4.49M	-2.99M	-1.5M